Stock quote - News

Amphion Innovations
AMP: 0.30 0.00 ( 0.00 %) delayed: 16:57PM


  • Amphion Innovations pledges Polarean Imaging stake as security for loan
    Monday 01 Apr 2019 12:52

    Amphion Innovations said it had pledged its holding of Polarean Imaging as additional security against a loan facility with its debt provider. The loan amount under the facility continued to be secured by the company's pledge of around 18m shares of Motif Bio. Amphion currently held about 18.8m...
    Read more

  • Amphion Innovations sells 1.8m shares in Motif Bio to repay debt
    Friday 15 Mar 2019 08:49

    Amphion Innovations said it had sold about 7% of its stake in its partner company, Motif Bio to repay a loan facility. The company sold 1,825,000 shares of Motif Bio, reducing its stake to 23,429,611, which represented 7.88% of the latter's total shares outstanding. The sale generated...
    Read more

  • Amphion Innovations sells 3m shares in Motif Bio
    Tuesday 21 Aug 2018 09:56

    Amphion Innovations said it had sold 3m shares in partner company Motif Bio to an institutional investor at 33.5p a share for approximately $1.273m. Following the sale, Amphion's stake in Motif was reduced to 8.51%. The proceeds of the sale of the Motif shares would be used as partial...
    Read more

  • Amphion Innovations cuts holding in Motif Bio to 8.5%
    Tuesday 21 Aug 2018 09:04

    Antibiotics developer Motif Bio noted that Amphion Innovations had sold some of its holding in the company to an institutional investor. Amphion now held 8.51% of the issued share capital of Motif Bio, the company said. According to Amphion's filing, it had previously held a 9.53% in Motif...
    Read more

  • Amphion Innovations swing to profit after value of investments jumps
    Tuesday 26 Jun 2018 14:57

    Amphion Innovations, a developer of medical and technology businesses, swung to an annual profit in 2017 after the value of its investments jumped. Pre-tax profit amounted to $2.5m, compared to a loss of $16.8m in 2016. An increase in the company's net asset value was due almost entirely to the...
    Read more

  • Amphion Innovations cuts Motif Bio stake to repay debt
    Wednesday 23 May 2018 14:23

    Amphion Innovations said it had sold shares in partner company Motif Bio to a US institutional investor for $3.7m and would use the proceeds to pay down debt. The shares were sold at 31p, leaving Amphibion with a 9.53% interest in Motif Bio. At 2:23pm: (LON:AMP) Amphion Innovations PLC share...
    Read more

  • Amphion Innovations participates in Polarean Imaging IPO
    Monday 26 Mar 2018 14:21

    Amphion Innovations said it said it had participated in an initial public offering of Polarean Imaging and would remain its biggest shareholder with a 23.2% stake. Polarean intended to raise up to £3m via a conditional placement and is expected to be admitted to AIM on 29 March with a market...
    Read more

  • Amphion agrees loan restructuring
    Friday 22 Dec 2017 07:09

    Amphion Innovations has agreed terms for re-structuring the loan payments and the draw-down of an additional US $1,550,000 under the loan facility announced in June 2014. The loan balance under the facility after the additional draw will be US $6,187,786 including fees and accrued interest...
    Read more

  • Amphion update on Polarean's proposed IPO
    Thursday 23 Nov 2017 09:36

    Amphion Innovations has issued a further update on its 26%-held Polarean Imaging. Amphion said that Polarean's proposed IPO and admission to AIM was now expected to complete in Q1 2018. The update said: 'Following publication of the Northland Research report, the management of Polarean is...
    Read more

  • Amphion update on Polarean Imaging
    Friday 10 Nov 2017 07:32

    Amphion Innovations has issued an update regarding its partner company Polarean Imaging Limited, in which Amphion currently has an interest of around 26%. The update said: 'Polarean is a revenue generating, late clinical stage medical company operating in the high resolution imaging market....
    Read more

  • DataTern case against MicroStrategy dismissed
    Thursday 02 Nov 2017 08:19

    Amphion Innovations said a case brought by its wholly-owned subsidiary DataTern against MicroStrategy Inc and certain of its customers has been dismissed. Amphion said the reason for the dismissal was the withdrawal of DataTern's legal counsel and the inability to identify and appoint a...
    Read more

  • Amphion partner releases positive clinical results
    Thursday 05 Oct 2017 07:35

    Amphion partner company Motif Bio has announced positive topline results for iclaprim in the REVIVE-2 phase 3 study. Amphion - which owns 14.1% of Motif Bio's issued share capital - said iclaprim met the primary endpoint and was well tolerated in the study. It said a new drug application was...
    Read more

  • Amphion revenues rise
    Friday 29 Sep 2017 07:49

    Amphion Innovations' revenues rose to $153,000 in the six months to the end of June compared with US $60,000 last time. The group said it continued to control costs and the board had continued to work with reduced levels of current cash compensation. Total administrative expenses were only...
    Read more

  • FLASH: Amphion pre-tax profits rise
    Friday 29 Sep 2017 07:02

    Story provided by StockMarketWire.com
    Read more

  • Amphion reduces stake in Motif Bio
    Wednesday 30 Aug 2017 09:51

    Amphion Innovations has soled 1,700,000 shares in partner company, Motif Bio, in partial repayment of the loan facility originally announced on 5 June 2014. Following this sale, Amphion holds 41,540,645 ordinary shares of Motif Bio, representing 15.8% of the issued share capital. At 9:51am:...
    Read more

  • FTSE falls on mixed bag led by utilities, oil majors
    Wednesday 28 Jun 2017 08:47

    London shares opened firmly lower on Wednesday with blue chips retreating on weakness in a palette of sectors, with utilities and oil majors prominent among them. Sterling was ahead on the dollar, but down on the euro. A short time after the open, the FTSE 100 was down 35.97 points, or 0.48%, to...
    Read more

  • FLASH: Amphion NAV falls
    Wednesday 28 Jun 2017 07:11

    Story provided by StockMarketWire.com
    Read more

  • Amphion partner company agrees merger
    Wednesday 31 May 2017 07:45

    Amphion Innovations partner company, m2m Acquisition Inc and North Carolina-based Polarean Inc have signed a definitive merger agreement in a cash and share-based transaction to create Polarean Imaging Limited, a newly incorporated company in the UK. In addition to the merger, Amphion also...
    Read more

  • FLASH: Amphion partner company agrees merger
    Wednesday 31 May 2017 07:10

    Story provided by StockMarketWire.com
    Read more

  • Amphion draws down additional $1.5m
    Tuesday 23 May 2017 08:37

    Amphion Innovations has agreed terms for the draw-down of an additional $1,500,000 under the loan facility announced on 5 June 2014 in two tranches of $750,000. Amphion said the first tranche was available yesterday on the signing of the agreement and the second tranche would become available...
    Read more

  • Amphion draws down additional $500,000
    Tuesday 07 Feb 2017 07:50

    Amphion Innovations has agreed terms for the draw-down of an additional tranche of $500,000 under the loan facility announced on 5 June 2014. The current loan balance under the facility after the additional draw will be $5,800,000. The additional draw may be converted into ordinary shares of...
    Read more

  • FLASH: Amphion draws down additional $500,000
    Tuesday 07 Feb 2017 07:06

    Story provided by StockMarketWire.com
    Read more

  • Amphion re-negotiates terms of Motif CPN
    Thursday 08 Sep 2016 08:51

    Amphion, a developer of medical, life science, and technology businesses, has re-negotiated the terms of the convertible promissory notes issued by Motif Bio, amounting to US $3,550,786, held by Amphion and its subsidiary Amphion Innovations US Inc. Under the original terms of the CPN, the CPN...
    Read more

  • FLASH: Amphion re-negotiates terms of Motif CPN
    Thursday 08 Sep 2016 07:13

    Story provided by StockMarketWire.com
    Read more

  • Amphion NAV up
    Wednesday 07 Sep 2016 07:57

    Amphion Innovations' net asset value per ordinary share rose to 4.3p in the six months to the end of June from 3.8p at year end. The group said the success of the AIM IPO of its partner company, Motif Bio plc, and the subsequent increase in the value of Amphion's shareholding in Motif, has been...
    Read more

  • FLASH: Amphion NAV up
    Wednesday 07 Sep 2016 07:07

    Story provided by StockMarketWire.com
    Read more

  • Amphion partner Motif Bio to list on NASDAQ
    Wednesday 13 Jul 2016 09:44

    Amphion Innovations' partner company Motif Bio has filed a registration with the US Securities and Exchange Commission for a proposed public offering American Depositary Shares. Motif Bio has also applied to have its ADSs listed on the NASDAQ Global Select Market under the ticker symbol 'MTFB'....
    Read more

  • FTSE mixed ahead of May becoming PM
    Wednesday 13 Jul 2016 08:59

    London equities opened mixed -- blue chips down and mid caps up -- as the UK moves to usher in Theresa May as Prime Minister after the non-binding Brexit vote for the country to quit the EU. Cautious markets are also looking to Bank of England's rates call tomorrow. Soon after the open, FTSE 100...
    Read more

  • Amphion NAV up
    Thursday 23 Jun 2016 08:17

    Amphion Innovations' net asset value per ordinary share stood at 3.8p at the end of December - an increase from 0.7p from the end of 2014. Amphion raised £2.1 million through the placing of new ordinary shares (June 2015) and the exercise of warrants throughout the period and had year-end...
    Read more

  • FLASH: Amphion NAV up
    Thursday 23 Jun 2016 07:11

    Story provided by StockMarketWire.com
    Read more

  • Amphion draws down $1,765,000
    Thursday 28 Apr 2016 09:52

    Amphion Innovations has agreed terms for the draw-down of an additional tranche of $1,765,000 under the loan facility announced on 5 June 2014. The interest rate will be 10% with repayments starting on 1 May and with the final repayment due on 1 February 2017. The proceeds are to be used to...
    Read more

  • FLASH: Amphion draws down $1,765,000
    Thursday 28 Apr 2016 07:25

    Story provided by StockMarketWire.com
    Read more

  • Amphion settles contested arbitration ruling
    Thursday 07 Apr 2016 07:55

    Amphion Innovations has reached a settlement over a claim filed against its subsidiary DataTern by Berkeley Research Group LLC. As previously reported, BRG, an expert consultant engaged by the Amphion's wholly owned subsidiary DataTern, filed for arbitration claiming that it was owed...
    Read more

  • FLASH: Amphion settles contested arbitration ruling
    Thursday 07 Apr 2016 07:10

    Story provided by StockMarketWire.com
    Read more

  • Director Deals - Amphion Innovations PLC (AMP)
    Thursday 07 Jan 2016 09:00

    Gerard Moufflet, Non Executive Director, received in lieu of fees/salary 93,750 shares in the company on the 7th January 2016 at a price of 3.38p. The Director now holds 1,273,958 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Amphion Innovations PLC (AMP)
    Thursday 07 Jan 2016 09:00

    Miroslaw Izienicki, Non Executive Director, received in lieu of fees/salary 198,056 shares in the company on the 7th January 2016 at a price of 3.38p. The Director now holds 601,489 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Amphion partner company m2m to merge
    Thursday 05 Nov 2015 07:51

    Amphion Innovations has signed a memorandum of understanding with an undisclosed pioneer and leader in advanced pulmonary imaging technology. Conditional upon the fulfillment of certain terms, and following the merger of Amphion's Partner Company, m2m Imaging Corp. with the private company,...
    Read more

  • FLASH: Amphion partner company m2m Imaging Corp to merge
    Thursday 05 Nov 2015 07:12

    Story provided by StockMarketWire.com
    Read more

  • Amphion chairman passes away
    Friday 30 Oct 2015 15:56

    Amphion Innovations has announced that R. James Macaleer, the Company's Chairman, passed away on Thursday 29 October 2015. Richard Morgan, CEO of Amphion, said, "It is with a heavy heart that we announce the passing of our Chairman, Jim Macaleer. Jim was a long-time friend and steadfast...
    Read more

  • Amphion CEO to present at London forum
    Thursday 17 Sep 2015 08:22

    Amphion Innovations chief executive Richard Morgan will present at Proactive Investors' One2One Forum on 24 September at the Chesterfield Mayfair Hotel in London, at 6 p.m. Graham Lumdsen, CEO of Amphion Partner Company, Motif Bio plc will also be presenting. At 8:22am: (LON:AMP) Amphion...
    Read more

  • Director Deals - Amphion Innovations PLC (AMP)
    Wednesday 16 Sep 2015 09:00

    Gerard Moufflet, Non Executive Director, received in lieu of fees/salary 93,750 shares in the company on the 11th September 2015 at a price of 6.25p. The Director now holds 1,180,208 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Amphion Innovations PLC (AMP)
    Wednesday 16 Sep 2015 09:00

    R. James Macaleer, Non Executive Director, received in lieu of fees/salary 285,000 shares in the company on the 11th September 2015 at a price of 6.25p. The Director now holds 26,096,881 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Director Deals - Amphion Innovations PLC (AMP)
    Wednesday 16 Sep 2015 09:00

    Miroslaw Izienicki, Non Executive Director, received in lieu of fees/salary 220,100 shares in the company on the 11th September 2015 at a price of 6.25p. The Director now holds 403,433 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
    Read more

  • Amphion's DataTern wins patent ruling
    Thursday 10 Sep 2015 08:14

    Amphion Innovations subsidiary DataTern has received a favourable ruling by the US District Court in Massachusetts, which denied two motions for summary judgment filed by MicroStrategy Inc seeking dismissal of DataTern's claims on the grounds of validity and infringement. In May of this year,...
    Read more

  • FLASH: Amphion's DataTern gets favourable ruling in US
    Thursday 10 Sep 2015 07:16

    Story provided by StockMarketWire.com
    Read more

  • FTSE rising on miners, airlines after US, Asia gains
    Thursday 03 Sep 2015 08:44

    FTSE indices continued yesterday's trudge higher in early deals on the back of improving miners and airline stocks, with several supermarkets, house builders and oil stocks also contributing. Wall St and Asian markets closed higher, supporting London's so-far positive impetus. Shortly after the...
    Read more

  • Amphion NAV jumps
    Thursday 03 Sep 2015 08:06

    Amphion Innovations' net asset value per ordinary share rose to 12.0p at the end of June - an increase from 0.7p at 31 December. Chief executive Richard Morgan said: "The dramatic rise in our net asset value per share was mainly due to the increase in the value of our holdings in Motif....
    Read more

  • FLASH: Amphion NAV up
    Thursday 03 Sep 2015 07:15

    Story provided by StockMarketWire.com
    Read more

  • Amphion resolutions passed at AGM
    Monday 10 Aug 2015 07:51

    Amphion Innovations - the developer of medical and technology businesses - has confirmed that all resolutions proposed at the annual general meeting on Friday were passed. Story provided by StockMarketWire.com
    Read more

  • FLASH: Motif Bio says final condition of ã22m placing satisfied
    Wednesday 22 Jul 2015 07:16

    Story provided by StockMarketWire.com
    Read more

Page 1 |

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.